{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:59:57Z","timestamp":1784077197075,"version":"3.55.0"},"reference-count":64,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2022,9,2]]},"abstract":"<jats:p>Parkinsonism-hyperpyrexia syndrome (PHS) and dyskinesia-hyperpyrexia syndrome (DHS) are rare but exhibit life-threatening complications in Parkinson\u2019s disease (PD). We herein presented two cases of PD patients and performed a comprehensive and comparative literature review for these two syndromes. The first case was diagnosed as PHS with cerebral salt wasting syndrome caused by abrupt withdrawal of antiparkinsonian medication. Her symptoms were gradually remitted with reinstitution of the medication. The second one was an early-stage PD patient diagnosed as DHS in association with abuse of antiparkinsonian drugs. Her symptoms were gradually remitted with reduced dosage of dopaminergic drugs. Results of literature reviews revealed a total of 56 and 13 cases of PHS and DHS, respectively, and they were more likely to occur in elderly and long-term PD patients. These two syndromes showed different female-to-male ratio, similar mortality, and different recovery time. There were stark differences between PHS and DHS, including triggers (abrupt drug stoppage versus drug abuse), symptoms (worsened tremor and rigidity versus continuous dyskinesia), and treatment (drug reinstitution versus drug reduction). In summary, our reports and the review provide new insights into PHS and DHS in association with PD and may facilitate rapid discrimination of the syndromes for timely and proper treatment to reduce mortality.<\/jats:p>","DOI":"10.3233\/jpd-223362","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:23:59Z","timestamp":1657279439000},"page":"1727-1735","source":"Crossref","is-referenced-by-count":19,"title":["Parkinsonism-Hyperpyrexia Syndrome and Dyskinesia-Hyperpyrexia Syndrome in Parkinson\u2019s Disease: Two Cases and Literature Review"],"prefix":"10.1177","volume":"12","author":[{"given":"Jian-Yong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, Institute of Geriatric Neurology, the Second Affiliated Hospital and Yuying Children\u2019s Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Fan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute of Geriatric Neurology, the Second Affiliated Hospital and Yuying Children\u2019s Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Guo","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute of Geriatric Neurology, the Second Affiliated Hospital and Yuying Children\u2019s Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Shi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute of Geriatric Neurology, the Second Affiliated Hospital and Yuying Children\u2019s Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Pei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute of Geriatric Neurology, the Second Affiliated Hospital and Yuying Children\u2019s Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei-Lei","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute of Geriatric Neurology, the Second Affiliated Hospital and Yuying Children\u2019s Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute of Geriatric Neurology, the Second Affiliated Hospital and Yuying Children\u2019s Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Department of Preventive Medicine, Institute of Nutrition and Diseases, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute of Geriatric Neurology, the Second Affiliated Hospital and Yuying Children\u2019s Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-223362_ref1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.3233\/JPD-223362_ref2","first-page":"15","article-title":"Emergencies and critical issues in Parkinson\u2019s disease","volume":"20","author":"Simonet","year":"2020","journal-title":"Pract Neurol"},{"key":"10.3233\/JPD-223362_ref3","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/mds.20689","article-title":"Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.1671; author reply","volume":"20","author":"Thomas","year":"2005","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-223362_ref4","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1002\/mds.23255","article-title":"Dyskinesia-hyperpyrexia syndrome: Another Parkinson\u2019s disease emergency","volume":"25","author":"Gil-Navarro","year":"2010","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-223362_ref5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/WNF.0000000000000155","article-title":"Summertime dyskinesia-hyperpyrexia syndrome: The \u201cdual heat\u201d hypothesis","volume":"39","author":"Herreros-Rodriguez","year":"2016","journal-title":"Clin Neuropharmacol"},{"key":"10.3233\/JPD-223362_ref6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00415-018-8789-8","article-title":"Heterogeneous pattern of autonomic dysfunction in Parkinson\u2019s disease","volume":"265","author":"Leclair-Visonneau","year":"2018","journal-title":"J Neurol"},{"key":"10.3233\/JPD-223362_ref7","doi-asserted-by":"crossref","first-page":"577128","DOI":"10.3389\/fneur.2020.577128","article-title":"Association analyses of autonomic dysfunction and sympathetic skin response in motor subtypes of Parkinson\u2019s disease","volume":"11","author":"Wang","year":"2020","journal-title":"Front Neurol"},{"key":"10.3233\/JPD-223362_ref8","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/01.STR.25.12.2483","article-title":"Hypothalamic dopamine release and local cerebral blood flow during onset of heatstroke in rats.2483-2486; discussion","volume":"25","author":"Kao","year":"1994","journal-title":"Stroke"},{"key":"10.3233\/JPD-223362_ref9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00005053-198105000-00011","article-title":"Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs","volume":"169","author":"Toru","year":"1981","journal-title":"J Nerv Ment Dis"},{"key":"10.3233\/JPD-223362_ref10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1212\/WNL.34.2.249","article-title":"Fatal hyperpyrexia after withdrawal of levodopa","volume":"34","author":"Sechi","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JPD-223362_ref11","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1001\/jama.1985.03360190098033","article-title":"A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal","volume":"254","author":"Friedman","year":"1985","journal-title":"JAMA"},{"key":"10.3233\/JPD-223362_ref12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/mds.870040408","article-title":"\u201cOn-off\u201d-induced lethal hyperthermia","volume":"4","author":"Pfeiffer","year":"1989","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-223362_ref13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5694\/j.1326-5377.1991.tb116385.x","article-title":"Neuroleptic malignant syndrome complicating levodopa withdrawal","volume":"155","author":"Reutens","year":"1991","journal-title":"Med J Aust"},{"key":"10.3233\/JPD-223362_ref14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archinte.1991.00400040130031","article-title":"Neuroleptic malignant syndrome in Parkinson\u2019s disease after withdrawal or alteration of dopaminergic therapy","volume":"151","author":"Keyser","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.3233\/JPD-223362_ref15","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.2169\/internalmedicine.31.1298","article-title":"Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson\u2019s disease","volume":"31","author":"Yamawaki","year":"1992","journal-title":"Intern Med"},{"key":"10.3233\/JPD-223362_ref16","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.43.5.1048","article-title":"Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period","volume":"43","author":"Mizuta","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JPD-223362_ref17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3143\/geriatrics.35.139","article-title":"[Malignant syndrome associated with disseminated intravascular coagulation and a high level of amylase in serum, followed by diabetic coma in an elderly patient with Parkinson\u2019s disease during L-dopa therapy]","volume":"35","author":"Saeki","year":"1998","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"10.3233\/JPD-223362_ref18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0002-9629(15)40575-0","article-title":"Acute hypernatremia and neuroleptic malignant syndrome in Parkinson disease","volume":"318","author":"Cao","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.3233\/JPD-223362_ref19","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/mds.1166","article-title":"Neuroleptic malignant syndrome in advanced Parkinson\u2019s disease","volume":"16","author":"Gordon","year":"2001","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-223362_ref20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.parkreldis.2003.09.001","article-title":"Malignant syndrome in Parkinson\u2019s disease","volume":"10","author":"Linazasoro","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-223362_ref21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/01.WNL.0000133409.53486.FF","article-title":"Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson disease","volume":"63","author":"Linazasoro","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JPD-223362_ref22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/bja\/aeh269","article-title":"Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication","volume":"93","author":"Stotz","year":"2004","journal-title":"Br J Anaesth"},{"key":"10.3233\/JPD-223362_ref23","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s00415-005-0798-8","article-title":"Parkinsonism-hyperpyrexia syndrome not related to antiparkinsonian treatment withdrawal during the 2003 summer heat wave","volume":"252","author":"Gaig","year":"2005","journal-title":"J Neurol"},{"key":"10.3233\/JPD-223362_ref24","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20380","article-title":"Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance","volume":"20","author":"Ladha","year":"2005","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-223362_ref25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/01376517-200506000-00008","article-title":"Neuroleptic malignant syndrome in a patient with Parkinson\u2019s disease: A case study","volume":"37","author":"Ward","year":"2005","journal-title":"J Neurosci Nurs"},{"key":"10.3233\/JPD-223362_ref26","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/ageing\/afl096","article-title":"It was not just a heatwave! Neuroleptic malignant-like syndrome in a patient with Parkinson\u2019s disease","volume":"35","author":"Douglas","year":"2006","journal-title":"Age Ageing"},{"key":"10.3233\/JPD-223362_ref27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jocn.2005.09.017","article-title":"Parkinsonism-hyperpyrexia syndrome: The role of electroconvulsive therapy","volume":"13","author":"Meagher","year":"2006","journal-title":"J Clin Neurosci"},{"key":"10.3233\/JPD-223362_ref28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mds.21172","article-title":"Fatal Parkinsonism-hyperpyrexia syndrome in a Parkinson\u2019s disease patient while actively treated with deep brain stimulation","volume":"22","author":"Factor","year":"2007","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-223362_ref29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/0972-2327.44562","article-title":"Malignant syndrome in Parkinson\u2019s disease without dopaminergic drug withdrawal","volume":"11","author":"Chandran","year":"2008","journal-title":"Ann Indian Acad Neurol"},{"key":"10.3233\/JPD-223362_ref30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neucli.2009.02.001","article-title":"Neuroleptic malignant syndrome and acute motor axonal neuropathy after Campylobacter jejuni infection","volume":"39","author":"Rajabally","year":"2009","journal-title":"Neurophysiol Clin"},{"key":"10.3233\/JPD-223362_ref31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12028-008-9125-4","article-title":"The parkinsonism-hyperpyrexia syndrome","volume":"10","author":"Newman","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.3233\/JPD-223362_ref32","doi-asserted-by":"crossref","first-page":"E1029","DOI":"10.1227\/01.NEU.0000367799.38332.43","article-title":"Parkinsonism-hyperpyrexia syndrome after deep brain stimulation surgery: Case report","volume":"66","author":"Kim","year":"2010","journal-title":"Neurosurgery"},{"key":"10.3233\/JPD-223362_ref33","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4103\/0028-3886.91380","article-title":"Deep brain stimulation surgery complicated by Parkinson hyperpyrexia syndrome","volume":"59","author":"Federico Landriel","year":"2011","journal-title":"Neurol India"},{"key":"10.3233\/JPD-223362_ref34","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/mds.23596","article-title":"Case report: Recurrent parkinsonism-hyperpyrexia syndrome following discontinuation of subthalamic deep brain stimulation","volume":"26","author":"Kadowaki","year":"2011","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-223362_ref35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1752-1947-5-255","article-title":"Malignant neuroleptic syndrome following deep brain stimulation surgery: A case report","volume":"5","author":"Themistocleous","year":"2011","journal-title":"J Med Case Rep"},{"key":"10.3233\/JPD-223362_ref36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.genhosppsych.2010.11.013","article-title":"Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson\u2019s disease\u2013a case report.301 e","volume":"33","author":"Wu","year":"2011","journal-title":"Gen Hosp Psychiatry"},{"key":"10.3233\/JPD-223362_ref37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10072-011-0710-5","article-title":"Constipation triggered the malignant syndrome in Parkinson\u2019s disease","volume":"33","author":"Ogawa","year":"2012","journal-title":"Neurol Sci"},{"key":"10.3233\/JPD-223362_ref38","doi-asserted-by":"crossref","first-page":"698","DOI":"10.12968\/hmed.2013.74.12.698","article-title":"Parkinsonism hyperpyrexia syndrome caused by abrupt withdrawal of ropinirole","volume":"74","author":"Arora","year":"2013","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.3233\/JPD-223362_ref39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/CPJ.0b013e3182a9c652","article-title":"Parkinsonism-hyperpyrexia syndrome: Broadening our differential diagnosis in the ICU","volume":"3","author":"Hocker","year":"2013","journal-title":"Neurol Clin Pract"},{"key":"10.3233\/JPD-223362_ref40","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/mds.25494","article-title":"Malignant deep brain stimulation-withdrawal syndrome in a patient with Parkinson\u2019s disease","volume":"28","author":"Neuneier","year":"2013","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-223362_ref41","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jocn.2012.04.024","article-title":"Neuroleptic malignant syndrome (parkinsonism-hyperpyrexia syndrome) after deep brain stimulation of the subthalamic nucleus","volume":"20","author":"Urasaki","year":"2013","journal-title":"J Clin Neurosci"},{"key":"10.3233\/JPD-223362_ref42","first-page":"271","article-title":"Neuroleptic malignant-like syndrome with a slight elevation of creatine-kinase levels and respiratory failure in a patient with Parkinson\u2019s disease","volume":"8","author":"Wei","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"10.3233\/JPD-223362_ref43","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1007\/s00415-015-7956-4","article-title":"Parkinsonism-hyperpyrexia syndrome and deep brain stimulation","volume":"262","author":"Artusi","year":"2015","journal-title":"J Neurol"},{"key":"10.3233\/JPD-223362_ref44","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.parkreldis.2015.08.004","article-title":"Parkinsonism hyperpyrexia syndrome following deep brain stimulation","volume":"21","author":"Govindappa","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-223362_ref45","first-page":"000368","article-title":"A fatal case of neuroleptic malignant syndrome after paralytic bowel in a patient taking antiparkinson medication","volume":"3","author":"Campa","year":"2016","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.3233\/JPD-223362_ref46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4266\/kjccm.2016.00087","article-title":"Malignant syndrome in Parkinson disease similar to severe infection","volume":"32","author":"Lee","year":"2017","journal-title":"Korean J Crit Care Med"},{"key":"10.3233\/JPD-223362_ref47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1213\/XAA.0000000000000462","article-title":"Whether to proceed with deep brain stimulator battery change in a patient with signs of potential sepsis and Parkinson hyperpyrexia syndrome: A case report","volume":"8","author":"Liu","year":"2017","journal-title":"A A Case Rep"},{"key":"10.3233\/JPD-223362_ref48","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/mdc3.12496","article-title":"Neuroleptic-like malignant syndrome after battery depletion in a patient with deep brain stimulation for secondary parkinsonism","volume":"4","author":"Sauer","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"10.3233\/JPD-223362_ref49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pjnns.2017.11.012","article-title":"Life-threatening parkinsonism-hyperpyrexia syndrome following bilateral deep brain stimulation of the subthalamic nucleus","volume":"52","author":"Akcakaya","year":"2018","journal-title":"Neurol Neurochir Pol"},{"key":"10.3233\/JPD-223362_ref50","doi-asserted-by":"crossref","unstructured":"Sahu H , Manjunath MB , Ray A , Vikram NK (2018) Neuroleptic malignant-like syndrome causing thrombocytopaenia: A rare association. BMJ Case Rep 11.","DOI":"10.1136\/bcr-2018-227089"},{"key":"10.3233\/JPD-223362_ref51","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/psychiatry.IndianJPsychiatry_113_18","article-title":"Parkinsonism-hyperpyrexia syndrome: A case report and review of literature","volume":"60","author":"Grover","year":"2018","journal-title":"Indian J Psychiatry"},{"key":"10.3233\/JPD-223362_ref52","doi-asserted-by":"crossref","unstructured":"Azar J , Elinav H , Safadi R , Soliman M (2019) Malignant deep brain stimulator withdrawal syndrome. BMJ Case Rep 12.","DOI":"10.1136\/bcr-2018-229122"},{"key":"10.3233\/JPD-223362_ref53","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10072-018-3696-4","article-title":"Malignant syndrome triggered by influenza A virus infection in a patient with Parkinson\u2019s disease with improvement after intravenous peramivir treatment","volume":"40","author":"Matsuzono","year":"2019","journal-title":"Neurol Sci"},{"key":"10.3233\/JPD-223362_ref54","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s13760-020-01316-3","article-title":"A case of refractory hypernatremia in the setting of parkinsonism-hyperpyrexia syndrome","volume":"120","author":"Ryu","year":"2020","journal-title":"Acta Neurol Belg"},{"key":"10.3233\/JPD-223362_ref55","doi-asserted-by":"crossref","first-page":"572","DOI":"10.9758\/cpn.2021.19.3.572","article-title":"Electroconvulsive therapy for Parkinson\u2019s disease with depression and neuroleptic malignant syndrome: A case report","volume":"19","author":"Mori","year":"2021","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.3233\/JPD-223362_ref56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/NRL.0000000000000330","article-title":"Parkinsonism-hyperpyrexia syndrome after amantadine withdrawal: Case report and review of the literature","volume":"26","author":"Dos Santos","year":"2021","journal-title":"Neurologist"},{"key":"10.3233\/JPD-223362_ref57","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5692\/clinicalneurol.55.182","article-title":"[Dyskinesia-hyperpyrexia syndrome in a patient with Parkinson\u2019s disease: A case report]","volume":"55","author":"Taguchi","year":"2015","journal-title":"Rinsho Shinkeigaku"},{"key":"10.3233\/JPD-223362_ref58","doi-asserted-by":"crossref","first-page":"154","DOI":"10.14802\/jmd.17022","article-title":"A patient with recurrent dyskinesia and hyperpyrexia syndrome","volume":"10","author":"Baek","year":"2017","journal-title":"J Mov Disord"},{"key":"10.3233\/JPD-223362_ref59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.parkreldis.2016.12.018","article-title":"Dyskinesia-hyperpyrexia syndrome under continuous dopaminergic stimulation","volume":"36","author":"Acebron Sanchez-Herrera","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-223362_ref60","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/mdc3.12663","article-title":"Dyskinesia-hyperpyrexia syndrome in Parkinson\u2019s disease: A heat shock-related emergency?","volume":"5","author":"Sarchioto","year":"2018","journal-title":"Mov Disord Clin Pract"},{"key":"10.3233\/JPD-223362_ref61","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.parkreldis.2019.05.018","article-title":"Dyskinesia-hyperpyrexia syndrome in Parkinson\u2019s disease with deep brain stimulation and high-dose levodopa\/carbidopa and entacapone","volume":"64","author":"Novelli","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-223362_ref62","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.neurol.2020.10.002","article-title":"Dyskinesia and hyperpyrexia syndrome: A case report and review of the literature","volume":"177","author":"Zu","year":"2021","journal-title":"Rev Neurol (Paris)"},{"key":"10.3233\/JPD-223362_ref63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5334\/tohm.641","article-title":"Rhabdomyolysis associated with severe levodopa-induced dyskinesia in Parkinson\u2019s disease: A report of two cases and literature review","volume":"11","author":"Pitakpatapee","year":"2021","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.3233\/JPD-223362_ref64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11910-017-0712-7","article-title":"Hyperkinetic movement disorder emergencies","volume":"17","author":"Cossu","year":"2017","journal-title":"Curr Neurol Neurosci Rep"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-223362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:52:04Z","timestamp":1777611124000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-223362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":64,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3233\/jpd-223362","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]}}}